344 related articles for article (PubMed ID: 1612123)
41. A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase.
Lider O; Cahalon L; Gilat D; Hershkoviz R; Siegel D; Margalit R; Shoseyov O; Cohen IR
Proc Natl Acad Sci U S A; 1995 May; 92(11):5037-41. PubMed ID: 7761444
[TBL] [Abstract][Full Text] [Related]
42. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
43. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases.
Parish CR; Coombe DR; Jakobsen KB; Bennett FA; Underwood PA
Int J Cancer; 1987 Oct; 40(4):511-8. PubMed ID: 3666989
[TBL] [Abstract][Full Text] [Related]
44. [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
[TBL] [Abstract][Full Text] [Related]
45. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage.
Katz BZ; Ishai-Michaeli R; Zusman T; Vlodavsky I; Witz IP
Invasion Metastasis; 1994-1995; 14(1-6):276-89. PubMed ID: 7657521
[TBL] [Abstract][Full Text] [Related]
46. Thrombin adhesive properties: induction by plasmin and heparan sulfate.
Bar-Shavit R; Eskohjido Y; Fenton JW; Esko JD; Vlodavsky I
J Cell Biol; 1993 Dec; 123(5):1279-87. PubMed ID: 8245131
[TBL] [Abstract][Full Text] [Related]
47. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
[TBL] [Abstract][Full Text] [Related]
48. Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase.
Yahalom J; Eldor A; Fuks Z; Vlodavsky I
J Clin Invest; 1984 Nov; 74(5):1842-9. PubMed ID: 6389600
[TBL] [Abstract][Full Text] [Related]
49. Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH.
Gilat D; Hershkoviz R; Goldkorn I; Cahalon L; Korner G; Vlodavsky I; Lider O
J Exp Med; 1995 May; 181(5):1929-34. PubMed ID: 7722469
[TBL] [Abstract][Full Text] [Related]
50. New Advances of Heparanase and Heparanase-2 in Human Diseases.
Jin H; Cui M
Arch Med Res; 2018 Oct; 49(7):423-429. PubMed ID: 30850186
[TBL] [Abstract][Full Text] [Related]
51. Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.
Bar-Shavit R; Eldor A; Vlodavsky I
J Clin Invest; 1989 Oct; 84(4):1096-104. PubMed ID: 2794047
[TBL] [Abstract][Full Text] [Related]
52. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
53. Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.
Vlodavsky I; Barash U; Nguyen HM; Yang SM; Ilan N
Semin Thromb Hemost; 2021 Apr; 47(3):240-253. PubMed ID: 33794549
[TBL] [Abstract][Full Text] [Related]
54. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
[TBL] [Abstract][Full Text] [Related]
55. Substrate specificity of heparanases from human hepatoma and platelets.
Pikas DS; Li JP; Vlodavsky I; Lindahl U
J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
[TBL] [Abstract][Full Text] [Related]
56. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
Nakajima M; Irimura T; Nicolson GL
Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
[TBL] [Abstract][Full Text] [Related]
57. Heparanases and tumor metastasis.
Nakajima M; Irimura T; Nicolson GL
J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
[TBL] [Abstract][Full Text] [Related]
58. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
[TBL] [Abstract][Full Text] [Related]
59. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.
Nakajima M; Irimura T; Di Ferrante N; Nicolson GL
J Biol Chem; 1984 Feb; 259(4):2283-90. PubMed ID: 6698965
[TBL] [Abstract][Full Text] [Related]
60. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
Brown KJ; Parish CR
Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
